Trinity Biotech (TRIB)
NASDAQ: TRIB
· Real-Time Price · USD
1.63
-0.28 (-14.66%)
At close: Aug 15, 2025, 3:59 PM
1.48
-9.20%
After-hours: Aug 15, 2025, 07:58 PM EDT
Trinity Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -16.96M | -4.76M | -6.76M | -3.32M | -5.5M | -6.72M | -5.99M | -5.81M | -10.08M | -8.95M | -21.96M | -20K | 5.73M | 2.23M | 4.46M | 1.6M |
Depreciation & Amortization | 424K | 598K | 153K | 691K | 462K | 229K | 484K | 602K | 668K | 744K | 261K | 700K | 1.83M | 800K | 1M | 800K |
Stock-Based Compensation | 140K | 250K | 114K | 812K | -1.01M | 738K | 975K | 1.36M | 1.32M | 119K | 122K | 197K | 158K | 252K | 313K | 380K |
Other Working Capital | 8.54M | -1.88M | 1.67M | -2.14M | 1.36M | -2.33M | -1.29M | -1.36M | 3.96M | 153K | -2.22M | -1.28M | 2.53M | -1.78M | -3.16M | 1.83M |
Other Non-Cash Items | 10.62M | 2.2M | 3.85M | 1.33M | 2.71M | 3.19M | 1.67M | 2.5M | 8.27M | 8.6M | 24.77M | -3.08M | -1.28M | 1.09M | -92K | -3.43M |
Deferred Income Tax | 585K | -35K | -131K | 67K | -3K | 222K | -267K | -11K | -16K | 3K | -29K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 8.54M | -1.88M | 1.67M | -2.14M | 2.29M | -2.33M | -1.29M | -1.36M | 2.11M | 153K | -2.2M | -1.28M | -1.88M | -1.78M | -3.15M | 1.83M |
Operating Cash Flow | 3.35M | -3.62M | -1.1M | -4.82M | -966K | -4.66M | -4.42M | -2.72M | 2.27M | 676K | 956K | -4.38M | 4.4M | 1.54M | 1.21M | 1.6M |
Capital Expenditures | -2.74M | -2.7M | -3.17M | -1.46M | -891K | -620K | -564K | -629K | -1.14M | -1.32M | -1.03M | -2.48M | -3.08M | -2.68M | -2.87M | -2.2M |
Cash Acquisitions | -1K | -403K | n/a | -12.5M | n/a | -266K | 28.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -700K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -2.58M | -2.59M | -3.1M | -13.9M | -641K | -758K | 28.01M | -1.05M | -662K | -1M | -1.66M | -13K | 2.84M | 1.09M | -2.15M | 2.2M |
Investing Cash Flow | -2.74M | -3.1M | -3.17M | -13.96M | -891K | -886K | 27.86M | -1.33M | -1.14M | -1.32M | -1.03M | -2.48M | -236K | -2.68M | -2.87M | -2.2M |
Debt Repayment | 1.34M | -678K | 5.9M | 21.12M | n/a | -571K | -10.49M | 4.25M | -599K | -684K | -15.23M | -7.4M | -818K | -700K | -743K | -701K |
Common Stock Repurchased | n/a | n/a | -270K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -74K | -2.19M | n/a | -2.27M | -1.76M | -1.86M | -2.96M | -2.65M | -804K | -1.69M | -5.46M | -5.47M | -4.97M | n/a | -2M | 1.76M |
Financial Cash Flow | 1.81M | 4.24M | 3.92M | 20.85M | -555K | -2.43M | -13.45M | 1.61M | -1.84M | -2.37M | 484K | -9.03M | -5.79M | -700K | -2M | -701K |
Net Cash Flow | 2.33M | -2.48M | -459K | 2.08M | -2.57M | -7.97M | 10.07M | -2.42M | -676K | -3.2M | 441K | -15.9M | -1.56M | -1.14M | -3.66M | 4.95M |
Free Cash Flow | 615K | -6.32M | -4.27M | -6.29M | -1.86M | -5.28M | -4.98M | -3.35M | 1.14M | -648K | -77K | -6.87M | 1.32M | -1.14M | -1.66M | -594K |